- Home
- ENTA vs RMBI Comparison
ENTA vs RMBI Comparison
Compare ENTA & RMBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- RMBI
- Stock Information
- Founded
- ENTA 1995
- RMBI 1887
- Country
- ENTA United States
- RMBI United States
- Employees
- ENTA N/A
- RMBI N/A
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- RMBI Major Banks
- Sector
- ENTA Health Care
- RMBI Finance
- Exchange
- ENTA Nasdaq
- RMBI Nasdaq
- Market Cap
- ENTA 164.6M
- RMBI 140.3M
- IPO Year
- ENTA 2013
- RMBI 2019
- Fundamental
- Price
- ENTA $7.84
- RMBI $14.81
- Analyst Decision
- ENTA Strong Buy
- RMBI
- Analyst Count
- ENTA 5
- RMBI 0
- Target Price
- ENTA $20.20
- RMBI N/A
- AVG Volume (30 Days)
- ENTA 164.6K
- RMBI 16.6K
- Earning Date
- ENTA 08-11-2025
- RMBI 10-23-2025
- Dividend Yield
- ENTA N/A
- RMBI 4.16%
- EPS Growth
- ENTA N/A
- RMBI 17.64
- EPS
- ENTA N/A
- RMBI 0.95
- Revenue
- ENTA $64,806,000.00
- RMBI $43,502,862.00
- Revenue This Year
- ENTA N/A
- RMBI N/A
- Revenue Next Year
- ENTA $1.65
- RMBI N/A
- P/E Ratio
- ENTA N/A
- RMBI $15.17
- Revenue Growth
- ENTA N/A
- RMBI 4.48
- 52 Week Low
- ENTA $4.09
- RMBI $11.37
- 52 Week High
- ENTA $13.37
- RMBI $15.15
- Technical
- Relative Strength Index (RSI)
- ENTA 45.61
- RMBI 57.15
- Support Level
- ENTA $7.28
- RMBI $14.01
- Resistance Level
- ENTA $8.86
- RMBI $14.66
- Average True Range (ATR)
- ENTA 0.53
- RMBI 0.38
- MACD
- ENTA -0.18
- RMBI -0.02
- Stochastic Oscillator
- ENTA 29.63
- RMBI 89.94
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.